Same-day versus delayed simulation imaging after placement of a perirectal hydrogel spacer for prostate radiotherapy.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1236113
- By:
- Publication type:
- Article
Works by Dimitri Bragilovski
Results: 6
1
2
Cisplatin-conjugated gold nanoparticles as a theranostic agent for head and neck cancer.
- Published in:
- Head & Neck, 2018, v. 40, n. 1, p. 70, doi. 10.1002/hed.24935
- By:
- Publication type:
- Article
3
SABR-Dual: a phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12165-1
- By:
- Publication type:
- Article
4
Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
5
The role of a radiopaque peri-rectal hydrogel spacer in aiding accurate daily image-guidance for prostate stereotactic radiotherapy.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1386058
- By:
- Publication type:
- Article
6
The Theoretical Value of Whole-Lung Irradiation for COVID-19 Pneumonia: A Reasonable and Safe Solution until Targeted Treatments are Developed.
- Published in:
- Radiation Research, 2021, v. 195, n. 5, p. 474, doi. 10.1667/RADE-20-00261.1
- By:
- Publication type:
- Article